{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T17:59:33Z","timestamp":1761674373244,"version":"3.37.3"},"reference-count":39,"publisher":"Informa UK Limited","issue":"8","funder":[{"name":"American Society of Hematology Physician-Scientist Career Development Award"},{"name":"Leukemia and Lymphoma Society Scholar in Clinical Research"},{"DOI":"10.13039\/100019346","name":"National Cancer Institute (NCI) Cancer Clinical Investigator Team Leadership","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019346","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Leukemia &amp; Lymphoma"],"published-print":{"date-parts":[[2024,7,2]]},"DOI":"10.1080\/10428194.2024.2344052","type":"journal-article","created":{"date-parts":[[2024,4,22]],"date-time":"2024-04-22T19:44:05Z","timestamp":1713815045000},"page":"1136-1144","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":2,"title":["Cost-effectiveness of adding quizartinib to induction chemotherapy for patients with\n            <i>FLT3-<\/i>\n            mutant acute myeloid leukemia"],"prefix":"10.1080","volume":"65","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3352-0902","authenticated-orcid":false,"given":"Jan Philipp","family":"Bewersdorf","sequence":"first","affiliation":[{"name":"Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kishan K.","family":"Patel","sequence":"additional","affiliation":[{"name":"Department of Medicine, Brigham and Women\u2019s Hospital, Boston, MA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8542-2944","authenticated-orcid":false,"given":"Rory M.","family":"Shallis","sequence":"additional","affiliation":[{"name":"Hematology Section, Department of Internal Medicine, Yale School of Medicine, New Haven, CT"},{"name":"Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale University, New Haven, CT"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolai A.","family":"Podoltsev","sequence":"additional","affiliation":[{"name":"Hematology Section, Department of Internal Medicine, Yale School of Medicine, New Haven, CT"},{"name":"Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale University, New Haven, CT"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tariq","family":"Kewan","sequence":"additional","affiliation":[{"name":"Hematology Section, Department of Internal Medicine, Yale School of Medicine, New Haven, CT"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Stempel","sequence":"additional","affiliation":[{"name":"Hematology Section, Department of Internal Medicine, Yale School of Medicine, New Haven, CT"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lourdes","family":"Mendez","sequence":"additional","affiliation":[{"name":"Hematology Section, Department of Internal Medicine, Yale School of Medicine, New Haven, CT"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maximilian","family":"Stahl","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Adult Leukemia Program, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eytan M.","family":"Stein","sequence":"additional","affiliation":[{"name":"Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott F.","family":"Huntington","sequence":"additional","affiliation":[{"name":"Hematology Section, Department of Internal Medicine, Yale School of Medicine, New Haven, CT"},{"name":"Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale University, New Haven, CT"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1624-4427","authenticated-orcid":false,"given":"George","family":"Goshua","sequence":"additional","affiliation":[{"name":"Hematology Section, Department of Internal Medicine, Yale School of Medicine, New Haven, CT"},{"name":"Center for Outcomes Research and Evaluation, Yale New Haven Hospital, New Haven, CT"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amer M.","family":"Zeidan","sequence":"additional","affiliation":[{"name":"Hematology Section, Department of Internal Medicine, Yale School of Medicine, New Haven, CT"},{"name":"Department of Medical Oncology, Adult Leukemia Program, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2024,4,22]]},"reference":[{"key":"e_1_3_4_2_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.v99.12.4326"},{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-08-109090"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1301689"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2022.280801"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2021.100905"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa074306"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022016867"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1614359"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1902688"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)00464-6"},{"key":"e_1_3_4_12_1","unstructured":"Administration USFaD. VANFLYTA\u00ae (quizartinib) tablets for oral use - Full prescribing information vol. 2024. 2024."},{"key":"e_1_3_4_13_1","volume-title":"European Hematology Association (EHA) 2023 Hybrid Congress","author":"Levis M.","year":"2023","unstructured":"Levis M. BMT-CTN 1506 (MORPHO): a randomized trial of the FLT3 inhibitor gilteritinib as posttransplant maintenance for FLT3-ITD AML. Oral abstract #LB2711. European Hematology Association (EHA) 2023 Hybrid Congress. Frankfurt, DE.; 2023."},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.03345"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30455-1"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40273-018-0732-4"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2021.27.10.1469"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.38737.607558.80"},{"key":"e_1_3_4_19_1","unstructured":"Lexi-Drugs. Lexicomp. Wolters Kluwer Health Inc. Riverwoods IL. Available at: http:\/\/online.lexi.com. Accessed August 29 2023"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2014.03.118"},{"key":"e_1_3_4_21_1","unstructured":"Department of Health and Human Services Office of Inspector General. Medicaid drug price comparison: average sales price to average wholesale price. 2005 06\/29\/2005."},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2021005472"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1080\/13696998.2018.1425209"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1080\/13696998.2017.1364648"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2023.2235044"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25000"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1080\/13696998.2018.1513847"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.1200\/JOP.2011.000469"},{"key":"e_1_3_4_29_1","unstructured":"Bureau of Economic Analysis USDoC. Table 2.5.4. Price indexes for personal consumption expenditures by function. Vol. 2023; 2023."},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1080\/13696998.2019.1584108"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.2147\/CEOR.S153286"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.12195"},{"key":"e_1_3_4_33_1","unstructured":"Social Security Administration. Actuarial life table. Vol. 2023; 2023."},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15030575"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020003902"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2022.2140288"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2021.2014453"},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30139-X"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2004444"},{"issue":"4","key":"e_1_3_4_40_1","first-page":"124","article-title":"Outcomes of patients with relapsed or refractory acute myeloid leukemia: a population-based real-world study","volume":"10","author":"Brandwein JM","year":"2020","unstructured":"Brandwein JM, Saini L, Geddes MN, et\u00a0al. Outcomes of patients with relapsed or refractory acute myeloid leukemia: a population-based real-world study. Am J Blood Res. 2020;10(4):124\u2013133.","journal-title":"Am J Blood Res"}],"container-title":["Leukemia &amp; Lymphoma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10428194.2024.2344052","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T22:51:17Z","timestamp":1727218277000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/10428194.2024.2344052"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,22]]},"references-count":39,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,7,2]]}},"alternative-id":["10.1080\/10428194.2024.2344052"],"URL":"https:\/\/doi.org\/10.1080\/10428194.2024.2344052","relation":{},"ISSN":["1042-8194","1029-2403"],"issn-type":[{"type":"print","value":"1042-8194"},{"type":"electronic","value":"1029-2403"}],"subject":[],"published":{"date-parts":[[2024,4,22]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ilal20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ilal20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-01-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-04-10","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-04-12","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-04-22","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}